Cerebrospinal fluid linezolid concentrations in postneurosurgical central nervous system infections.
about
Linezolid for the treatment of Nocardia spp. infectionsPediatric anthrax clinical managementRetrospective analysis of the risk factors for linezolid-induced thrombocytopenia in adult Japanese patients.Penetration of drugs through the blood-cerebrospinal fluid/blood-brain barrier for treatment of central nervous system infections.Linezolid for the treatment of drug-resistant infections.Serum and cerebrospinal fluid concentrations of linezolid in neurosurgical patients.Pharmacokinetics of intravenous linezolid in cerebrospinal fluid and plasma in neurointensive care patients with staphylococcal ventriculitis associated with external ventricular drains.Treatment of meningitis due to methicillin-resistant Staphylococcus epidermidis with linezolid.Pharmacodynamics of antibiotics to treat multidrug-resistant Gram-positive hospital infections.Pharmacologic options for CNS infections caused by resistant Gram-positive organisms.Surveillance and management of multidrug-resistant microorganisms.Bacterial meningitis: new therapeutic approaches.Treatment strategies for central nervous system infections: an update.Bacterial meningitis: an update of new treatment options.Linezolid for the treatment of central nervous system infections in neurosurgical patients.Treatment with linezolid in a neonate with meningitis caused by methicillin-resistant Staphylococcus epidermidis.Sequential antimicrobial treatment with linezolid for neurosurgical infections: efficacy, safety and cost study.Postoperative meningitis in patients with cervical cord tumor: a case report.Neuroprotective potential of Linezolid: a quantitative and distribution study via mass spectrometry.Vancomycin versus linezolid in the treatment of methicillin-resistant Staphylococcus aureus meningitis in an experimental rabbit modelCenters for disease control and prevention expert panel meetings on prevention and treatment of anthrax in adults.Linezolid penetration into cerebrospinal fluid and brain tissue.Linezolid in the treatment of methicillin-resistant staphylococcal post-neurosurgical meningitis: a series of 17 cases.Clinical experience with linezolid for the treatment of nocardia infection.Successful treatment of meningoencephalitis caused by methicillin-resistant Staphylococcus aureus with intrathecal vancomycin in an allogeneic peripheral blood stem cell transplant recipient.Successful treatment of meningoencephalitis caused by methicillin-resistant Staphylococcus aureus with intravenous linezolid in an allogeneic cord blood stem cell transplant recipient.Linezolid for the treatment of a heteroresistant Staphylococcus aureus shunt infection.Clinical experience with linezolid for the treatment of central nervous system infections.Clinical Pharmacokinetics and Pharmacodynamics of Oxazolidinones.Linezolid cerebrospinal fluid concentration in central nervous system infection.Successful treatment and cerebrospinal fluid penetration of oral linezolid in a patient with coagulase-negative Staphylococcus ventriculitis.Effective CSF concentrations achieved with continuous-infusion flucloxacillin in a child
P2860
Q28245032-4BA7691D-87C3-4405-9ED1-AED1F5072202Q28397091-A5C72939-E081-432B-800E-EE1902E47924Q33415838-E45473F2-F856-4B41-9FC8-C964FF9CA541Q34142328-32491640-48DF-43EB-810C-C44E08E5EDA1Q34894133-CD3B7D04-9AA0-482A-AD81-7089175BB093Q35215457-3440394E-0715-4813-A09C-67A7971B1472Q35635671-D87F922E-CFC0-46B1-8A93-0E39DB19C3D6Q36240752-0CC23DBF-1482-47AC-AF46-3D952B388419Q36777850-3759C058-A60B-4CB8-9763-F1840DCE83FAQ37077629-0FBEAE67-A9E8-48A1-A14A-4C2F55F5986FQ37912231-8D7AA48A-68A1-4D8D-8269-CFEA566D3E94Q38145360-982FE4B3-2107-4451-B9D4-56DB0E77A110Q38261298-22B7519A-E249-454D-A599-1D1AFB411884Q38570487-1132E18A-769B-496B-855B-4AB85D9AC9A8Q39559123-542DBE5A-6C94-4E05-B869-55A50BED9BCFQ40256274-B3BD50AB-721A-407A-8635-6871FBAD725CQ40577600-E086A653-C5CA-4B22-8D0E-2EC8EE08AEC9Q41250796-8E4A7904-4516-4086-83B9-562732AA4BDEQ42101970-06383D0B-4F2E-4E9B-B995-9D2DAC15A246Q42288289-37881F94-111A-47DA-82F7-069CCEBF15AFQ42735019-6D82EE87-CB95-458E-9DA0-8F5FF277B242Q43130393-7389FBA5-264E-495F-90B0-90DEC0F18C95Q44047004-C1D212CA-4486-49F6-B824-E419E946EE3CQ44285699-CD76829A-E405-4E03-85F5-3E2BE3C3782CQ44351375-F7A20428-0894-4243-9E1B-570191A714CFQ46465912-3E39A91D-3758-474F-9DDA-9B62FCE732EAQ46533720-31985F95-4DF2-412B-97D4-E6BB5D0BED87Q46548640-387F8AFC-47B9-4025-90E9-79155EFBE680Q47611899-50F974D9-4332-4047-871A-322247D21B22Q48268927-EC8415A8-FB02-4B3B-B57C-59EE0609A08BQ48497879-96C4B3CE-2BE4-4B4A-9B03-A93315BF6CB2Q57080382-6140318B-0480-43BA-A1D8-B1D6FA324EED
P2860
Cerebrospinal fluid linezolid concentrations in postneurosurgical central nervous system infections.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Cerebrospinal fluid linezolid ...... ral nervous system infections.
@en
Cerebrospinal fluid linezolid ...... ral nervous system infections.
@nl
type
label
Cerebrospinal fluid linezolid ...... ral nervous system infections.
@en
Cerebrospinal fluid linezolid ...... ral nervous system infections.
@nl
prefLabel
Cerebrospinal fluid linezolid ...... ral nervous system infections.
@en
Cerebrospinal fluid linezolid ...... ral nervous system infections.
@nl
P2093
P2860
P1476
Cerebrospinal fluid linezolid ...... ral nervous system infections.
@en
P2093
Cristini F
Regazzi MB
P2860
P304
P356
10.1128/AAC.46.3.936-937.2002
P407
P577
2002-03-01T00:00:00Z